共 137 条
[1]
Siegel RL(2017)Cancer statistics, 2017 CA Cancer J Clin 67 7-30
[2]
Miller KD(2013)A road map to comprehensive androgen receptor axis targeting for castration-resistant prostate cancer Cancer Res 73 4599-4605
[3]
Jemal A(2014)Androgen metabolic pathway involved in current and emerging treatment for men with castration resistant prostate cancer: intraprostatic androgens as therapeutic targets and endocrinological biomarkers Curr Drug Targets 15 1215-1224
[4]
Mitsiades N(2012)Distinct patterns of dysregulated expression of enzymes involved in androgen synthesis and metabolism in metastatic prostate cancer tumors Cancer Res 72 6142-6152
[5]
Hara N(2013)Development, validation and application of a stable isotope dilution liquid chromatography electrospray ionization/selected reaction monitoring/mass spectrometry (SID-LC/ESI/SRM/MS) method for quantification of keto-androgens in human serum J Steroid Biochem Mol Biol 138 281-289
[6]
Nishiyama T(2015)CYP3A5 regulates prostate cancer cell growth by facilitating nuclear translocation of AR Prostate 75 527-538
[7]
Mitsiades N(2014)Importance of 5alpha-reductase gene polymorphisms on circulating and intraprostatic androgens in prostate cancer Clin Cancer Res 20 576-584
[8]
Sung CC(2009)Understanding the epidemiology, natural history, and key pathways involved in prostate cancer Urology 73 S4-10
[9]
Schultz N(2014)5alpha-reductase type 3 enzyme in benign and malignant prostate Prostate 74 235-249
[10]
Danila DC(2008)A phase II study of mifepristone (RU-486) in castration-resistant prostate cancer, with a correlative assessment of androgen-related hormones BJU Int 101 1084-1089